Vyndamax 61 MG capsule UD 30S
Ended Awarded Last action
- Contract number
- SPE2DR26F6CR5
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,593
Award facts
- Contract value 100% obligated
- $14,592.57 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, awarded January 6, 2026, by the Defense Logistics Agency to AmerisourceBergen Drug Corp, provides $14,592.57 in firm fixed-price pharmaceuticals, specifically VYNDAMAX 61 MG capsules in unit dose packages of 30 units. The contract, which is not set-aside and was competitively awarded, is scheduled for completion by January 28, 2026, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031, which serves as the primary vehicle for delivering comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen, a major pharmaceutical distributor headquartered in Pennsylvania, is a critical vendor in the federal medical supply chain, regularly providing brand-name and generic medications, vaccines, and specialized medical commodities across multiple therapeutic domains to military treatment facilities and veterans' healthcare systems. The DLA's Medical Supply Chain relies on such delivery orders to ensure consistent access to essential pharmaceuticals supporting the Defense Health Agency and other government healthcare programs. This transaction exemplifies the efficient procurement structure through which AmerisourceBergen fulfills government medical requirements on an ongoing basis.
Quick answers
Who was awarded contract SPE2DR26F6CR5?
SPE2DR26F6CR5 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 6, 2026.
How much is contract SPE2DR26F6CR5 worth?
The government has obligated $14,593 on SPE2DR26F6CR5.
Is contract SPE2DR26F6CR5 an order under another contract?
Yes. SPE2DR26F6CR5 is a delivery order under SPE2DR25D1052, an indefinite delivery contract.
Was contract SPE2DR26F6CR5 competed?
The extent of competition for SPE2DR26F6CR5 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award